Arrowhead Pharmaceuticals, Inc. (ARWR)
NASDAQ: ARWR · Real-Time Price · USD
48.31
-9.85 (-16.94%)
Nov 9, 2026, 1:56 PM EST - Market open
Arrowhead Pharmaceuticals Employees
Arrowhead Pharmaceuticals had 711 employees as of September 30, 2025. The number of employees increased by 102 or 16.75% compared to the previous year. That makes Arrowhead Pharmaceuticals the 17,341st largest employer in the world and 2,397th in the United States.
Employees
711
Change (1Y)
102
Growth (1Y)
16.75%
Revenue / Employee
$941,624
Profits / Employee
-$450,007
Market Cap
6.82B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2025 | 711 | 102 | 16.75% |
| Sep 30, 2024 | 609 | 84 | 16.00% |
| Sep 30, 2023 | 525 | 128 | 32.24% |
| Sep 30, 2022 | 397 | 68 | 20.67% |
| Sep 30, 2021 | 329 | 97 | 41.81% |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Twist Bioscience | 979 |
| Madrigal Pharmaceuticals | 915 |
| Corcept Therapeutics | 730 |
| ImmunityBio | 691 |
| Cytokinetics | 673 |
| Rhythm Pharmaceuticals | 414 |
| TG Therapeutics | 399 |
| Krystal Biotech | 295 |
ARWR News
- 1 hour ago - Arrowhead falls -17.7% - TheFly
- 3 hours ago - Arrowhead falls -15.4% - TheFly
- 22 hours ago - Arrowhead presents results on two of RNAi based therapies in pipeline at AHA - TheFly
- 1 day ago - Arrowhead Pharmaceuticals Presents Plozasiran Data Highlighting Sustained Triglyceride Reductions and Reduced Acute Pancreatitis Rates - Business Wire
- 5 days ago - Arrowhead refinances existing credit facility - TheFly
- 5 days ago - Arrowhead Pharmaceuticals Refinances Existing Credit Facility, Lowering Borrowing Costs and Extending Maturity - Business Wire
- 5 days ago - Arrowhead Pharmaceuticals to Webcast 2026 Fiscal Year-End Results - Business Wire
- 7 days ago - Arrowhead Pharmaceuticals to Present Important Clinical Data at the American Heart Association Scientific Sessions 2026 - Business Wire